Experience
-
Board Member at Xenimmune Therapeutics
Jun 2024 - Present · 2 yrs 2 mos
XenImmune is a pioneering immuno-oncology company applying the powerful and proven biology of organ transplant hyperacute rejection to fight cancer.
-
Board Member at Accent Therapeutics, Inc.
Nov 2023 - Present · 2 yrs 9 mos
Accent Therapeutics is focused on developing small molecule cancer drugs that target RNA-modifying proteins (RMPs) to treat difficult-to-treat cancers.
-
Director, AbbVie Ventures at AbbVie
Oct 2023 - Present · 2 yrs 10 mos
-
Senior Associate, Investment Banking at Back Bay Life Science Advisors
May 2021 - Jul 2023 · 2 yrs 3 mos
-
Chief Operating Officer at Fitango Health
Dec 2018 - May 2021 · 2 yrs 6 mos